CD8 alpha&beta Heterodimer, His & Flag, Human
| $430.00 | |
| Z04227-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $430.00 | |
| Z04227-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 23.54 kDa (CD8 alpha) and 22.62 kDa (CD8 beta) | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 26-28 kDa (CD8 alpha) and 28-32 kDa (CD8 beta) on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized CD8 alpha&beta Heterodimer, His & Flag, Human, His Tag at 2 μg/ml (100 μL/well) on the plate. Dose response curve for Anti-CD8 Antibody, hFc Tag with the EC50 of 11.3 ng/ml determined by ELISA. »
The purity of CD8 alpha&beta Heterodimer, His & Flag, Humanr is greater than 95% as determined by SEC-HPLC. »
CD8 alpha&beta Heterodimer, His & Flag, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | CD8 alpha&beta (CD8αβ) is a heterodimeric form of CD8. CD8α is required for surface expression of CD8β. The extracellular IgV-like domain of CD8α interacts with the α3 portion of the class I MHC molecule. CD8αβ is expressed on human peripheral T cells and functions as a coreceptor and can greatly increase the sensitivity and breadth of antigen recognition by CD8+ peripheral T cells bearing TCR. |
| Synonyms | CD8 alphaβ CD8A&CD8B |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.